MEDS 8-K: SEC filing

Filed with the SEC on · accession 0001493152-26-050033

MEDS filed a 8-K (current report) with the SEC on Nov 5, 2026. DataMeds AI terminated its Second Amended and Restated Letter of Intent with Datavault AI, REBOOT Health AI, EOS Technology Holdings, Scilex Holding, and HealthBridge Advisors for the in-license or acquisition of IP in exchange for Company common stock due to market conditions.

Summary of the filing

DataMeds AI terminated its Second Amended and Restated Letter of Intent with Datavault AI, REBOOT Health AI, EOS Technology Holdings, Scilex Holding, and HealthBridge Advisors for the in-license or acquisition of IP in exchange for Company common stock due to market conditions. No fees or obligations are owed, and no shares will be issued under the terminated LOI, while the company's exclusive license with REBOOT and its agreement with Datavault AI remain in effect.

Key details

FilerDataMeds AI, Inc.
Counterparty to terminated loiDatavault AI Inc.
Counterparty to terminated loi; exclusive license remains in effectREBOOT Health AI, Inc.
Counterparty to terminated loiEOS Technology Holdings, Inc.
Counterparty to terminated loiScilex Holding Company
Counterparty to terminated loiHealthBridge Advisors, LLC

✦ Ask GOAX AI about this filing — what it means for MEDS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MEDS?

Click here

Frequently asked questions

What did MEDS file with the SEC on Nov 5, 2026?

MEDS filed a 8-K (SEC filing). DataMeds AI terminated its Second Amended and Restated Letter of Intent with Datavault AI, REBOOT Health AI, EOS Technology Holdings, Scilex Holding, and HealthBridge Advisors for the in-license or acquisition of IP in exchange for Company common stock due to market conditions. No fees or obligations are owed, and no shares will be issued under the terminated LOI, while the company's exclusive license with REBOOT and its agreement with Datavault AI remain in effect.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other MEDS SEC filings

Get alerts when MEDS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days